Clinical trial
A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in…
NCT00256997 · Janssen-Ortho Inc., Canada, Industry · Terminated
Key facts
| NCT number | NCT00256997 |
|---|---|
| Title | A Study of Risperidone Long-Acting Injection Versus Oral Antipsychotics in Schizophrenia Participants With a History of Being Poorly Compliant With Taking Their Medication |
| Official title | Pragmatic Randomized Trial of Risperdal Consta Versus Oral Atypical Antipsychotics in Poorly Adherent Subjects With Schizophrenia in a Routine Care Setting |
| Lead sponsor | Janssen-Ortho Inc., Canada, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Risperidone long-acting injection (LAI), Oral atypical Antipsychotic |
| Enrollment | 167 |
| Start date | Jan 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Apr 1, 2009 |
| First posted | Nov 22, 2005 |
| Last update posted | Dec 5, 2013 |
| Countries | Australia, Canada, Ireland, United Kingdom |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: